Budecort Rotacaps

Company name Cipla Ltd.
Generic drug Budesonide
Indications: Budecort Rotacaps are indicated for a wide range of patients with bronchial asthma. These include those whose asthma is poorly controlled by bronchodilators alone; those who are inadequately controlled by sodium cromoglycate in addition to bronchodilators; those with severe asthma who are dependent on systemic corticosteroids or adrenocorticotrophic hormone (ACTH) or its synthetic equivalent. Budecort Rotacaps are particularly important for managing asthma in children because good control can be achieved without retardation of growth.

Presentation  
Formulation type Package type Quantity per pack
Capsules 100 mcg Container 30
Capsules 200 mcg Container 30
Capsules 400 mcg Container 30



Source : Cipla Ltd.
NOTE : The Information presented above is a verbatim rendering of the prescribing information provided by the marketing / manufacturing company which owns the brand.


|Expert's View | Do and Learn | How I Cured | How to Consult a Doctor | Understanding Asthma |  Diagnosis | Triggers |
| Therapy | Special Issues | Asthma and Allergy | Discussion Forum | Books | Articles | Drugs | Shopping Cart |
 | Medline | Online Consultation | Chat |  News | Disclaimer | About Us | Advertise |
| FAQ | Contact Us | Feedback | Site Map |Asthma Glossary|

| E-mail webmaster |

© Copyright 2001-2002 Asthmacure.com - All rights reserved
®  Asthmacure.com is a registered trademark